A new report underlines that vaccination, screening, treatment and public awareness, provide the cornerstone for eliminating human papillomavirus (HPV) in Europe. The report was published by The European Cancer Organisation, Brussels on 7th October.1 The [more]
In patients with early cervical cancer, minimally invasive surgery is likely not the best option, according to two studies with “alarming data” appearing in the latest issue of the New England Journal of Medicine. “Minimally [more]
How far can private and philanthropic providers meet the rapidly rising need for cancer detection, treatment and care in low- and middle-income countries? Sandhya Srinivasan reports on a high-profile debate involving economists, policy makers, clinicians [more]
Given how preventable cervical cancer is, setting up screening programmes must be a key element in Europe’s cancer strategy. But as this six country initiative is finding out, it takes a lot. Download full article
Working at a massive hospital in a country with high rates of advanced women’s cancers gave Vesna Kesic the ideal opportunity to hone her skills as a gynaecological oncology surgeon. Thanks to her commitment to [more]
Cisplatin-based chemoradiation has been shown to be superior to radiotherapy plus hydroxyurea for stage IB to III cervical cancer, conferring better survival rates withmodest long-term toxicity. Download full article
The new HPV vaccines have shown impressive results in their target population, but if immunisation programmes come at the expense of existing or planned cytological screening, deaths from cervical cancer may increase. Download full article
German virologist Harald zur Hausen was convinced by the early 1970s that the skin wart virus, human papilloma, was implicated in cervical cancer. Thirty years later we stand on the threshold of a vaccine to [more]